You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BGB-11417

Showing 1 - 25 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • +2 more
  • BGB-11417
  • (no location specified)
Jul 18, 2023

Healthy Volunteers Trial ([14C]-BGB-11417)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Apr 25, 2023

CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

Not yet recruiting
  • CLL
  • (no location specified)
Oct 3, 2023

Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma Trial (BGB-11417)

Not yet recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • BGB-11417
  • (no location specified)
Jul 25, 2022

Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

Not yet recruiting
  • Leukemia
  • +4 more
  • BGB-11417
  • (no location specified)
Jul 27, 2022

Acute Myeloid Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumor Trial in Worldwide (BGB-11417, Azacitidine, Posaconazole)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • BGB-11417
  • +2 more
  • Houston, Texas
  • +23 more
Aug 18, 2022

Mature B-cell Malignancies Trial in Suzhou (BGB-11417)

Recruiting
  • Mature B-cell Malignancies
  • BGB-11417
  • Suzhou, Jiangsu, China
    First Affiliated Hospital of Suzhou University
Aug 4, 2021

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (BGB-11417, Dexamethasone, Carfilzomib)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • BGB-11417
  • +2 more
  • Birmingham, Alabama
  • +21 more
Aug 8, 2022

Mature B-Cell Malignancies Trial in Worldwide (BGB-11417, Zanubrutinib)

Recruiting
  • Mature B-Cell Malignancies
  • Stanford, California
  • +26 more
Dec 16, 2021

Advanced Solid Tumor, Solid Tumor Trial (BGB-26808, Tislelizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • Solid Tumor
  • (no location specified)
Aug 7, 2023

Solid Tumors Trial (BGB-B167, Tislelizumab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Dec 1, 2022

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Solid Tumor Trial in Australia, United States (BGB-B167, Tislelizumab)

Not yet recruiting
  • Solid Tumor
  • Duarte, California
  • +6 more
Aug 8, 2022

Lymphoma, Leukemia Trial in Australia, China (Zanubrutinib, Tislelizumab)

Completed
Has Results
  • Lymphoma
  • Leukemia
  • Darlinghurst, New South Wales, Australia
  • +9 more
Mar 16, 2022

NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Sep 6, 2023

Advanced or Inoperable Gastric Cancer Trial in Worldwide (pamiparib, Placebo)

Completed
  • Advanced or Inoperable Gastric Cancer
  • Santa Rosa, California
  • +140 more
Jan 10, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Solid Tumor Trial in Australia, France, United States (BGB-A3055, Tislelizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • Iowa City, Iowa
  • +7 more
Jul 5, 2023

Advanced Solid Tumor Trial in Australia, New Zealand, United States (BGB-A445, tislelizumab)

Recruiting
  • Phase 1a:Advanced Solid Tumors; Phase 1b: Non-small Cell Lung Cancer (NSCLC) and Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pittsburgh, Pennsylvania
  • +11 more
Aug 25, 2022

Relapsed Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma Trial in Beijing (Ociperlimab, Tislelizumab,

Recruiting
  • Relapsed Diffuse Large B-cell Lymphoma
  • Refractory Diffuse Large B-cell Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 4, 2022

Solid Tumor, B-Raf Mutation-Related Tumors Trial in Australia, United States (BGB-3245)

Recruiting
  • Solid Tumor
  • B-Raf Mutation-Related Tumors
  • Boston, Massachusetts
  • +4 more
Oct 25, 2022

Not Determined Trial in Australia, China (BGB-23339, Placebo)

Recruiting
  • Not Determined
  • Herston, Queensland, Australia
  • +3 more
Aug 9, 2022

Healthy Volunteers Trial in Las Vegas (BGB-23339, Placebo)

Withdrawn
  • Healthy Volunteers
  • Las Vegas, Nevada
    PPD
Dec 14, 2022

B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

Recruiting
  • B-cell Malignancy
  • +8 more
  • Phoenix, Arizona
  • +14 more
Jan 17, 2023

Richter Transformation Trial in Austria, Denmark, Germany (Tislelizumab, Zanubrutinib)

Recruiting
  • Richter Transformation
  • Vienna, Austria
  • +11 more
Mar 8, 2022

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022